Ds Healthcare Group Quick Ratio (DSKX) starting from the second quarter 2017 to second quarter 2016, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Ds Healthcare Group, Inc.  (DSKX)

Ds Healthcare Group's Quick Ratio

DSKX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2017, Quick Ratio fell to 0.05 below Ds Healthcare Group, Inc. average.

Within Biotechnology & Pharmaceuticals industry 85 other companies have achieved higher Quick Ratio than Ds Healthcare Group in second quarter 2017. While Quick Ratio total ranking in the second quarter 2017 has deteriorated compared to the prior quarter from 4430 to 5127.

Explain Quick Ratio?
How much Cash & cash equivalents DSKX´s has?
What are DSKX´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DSKX Quick Ratio (Jun 30 2017)
Q2		 (Mar 31 2017)
Q1		 (Dec 31 2016)
Q4		 (Sep 30 2016)
Q3		 (Jun 30 2016)
Q2
Y / Y Current Liabilities Change 70.61 % 48.64 % 29.68 % 11.47 % 30.62 %
Y / Y Cash & cash equivalent Change -83.73 % -75.25 % -92.87 % -34.99 % 71.39 %
Quick Ratio MRQ 0.05 0.15 0.08 0.25 0.49
DSKX's Total Ranking # 5127 # 4430 # 5322 # 3808 # 3118
Seq. Current Liabilities Change 38.22 % -1.77 % 20.41 % 4.36 % 20.42 %
Seq. Cash & cash equivalent Change -58.1 % 102.18 % -63.95 % -46.72 % -36.26 %



Quick Ratio second quarter 2017 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 86
Healthcare Sector # 794
Overall Market # 4609


Quick Ratio Statistics
High Average Low
1.37 0.36 -0.6
(Dec 31 2015)   (Sep 30 2011)




Financial Statements
Ds Healthcare Group's Current Liabilities $ 6 Millions Visit DSKX's Balance sheet
Ds Healthcare Group's Cash & cash equivalent $ 0 Millions Visit DSKX's Balance sheet
Source of DSKX's Sales Visit DSKX's Sales by Geography


Cumulative Ds Healthcare Group's Quick Ratio

DSKX's Quick Ratio for the trailling 12 Months

DSKX Quick Ratio

 (Jun 30 2017)
12 Months		 (Mar 31 2017)
12 Months		 (Dec 31 2016)
12 Months		 (Sep 30 2016)
12 Months		 (Jun 30 2016)
12 Months
Y / Y Current Liabilities TTM Growth 40.29 % 29.51 % 14.49 % 5.44 % 4.2 %
Y / Y Cash & cash equivalent TTM Growth -79.02 % -62.69 % -26.54 % 135.13 % 213.61 %
Quick Ratio TTM 0.12 0.23 0.39 0.74 0.8
Total Ranking TTM # 3736 # 3704 # 2332 # 2335 #
Seq. Current Liabilities TTM Growth 15.57 % 9.78 % 7.48 % 2.87 % 6.7 %
Seq. Cash & cash equivalent TTM Growth -39.62 % -35.84 % -43.15 % -4.72 % 7.35 %

Quick ratio ranking by company, industry and sector >> Back to DSKX Financial Strength Comparisons >> Go to Compare DSKX Quick Ratio to its Competitors

On the trailing twelve months basis Due to growth in Current Liabilities in the Q2 2017 to $5.82 millions, cumulative Quick Ratio decreased to 0.12 below the Ds Healthcare Group, Inc. average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 52 other companies have achieved higher Quick Ratio than Ds Healthcare Group. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2017 from 3704 to 3736.

Explain Quick Ratio?
How much Cash & cash equivalents DSKX´s has?
What are DSKX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 53
Healthcare Sector # 510
Within the Market # 3736


trailing twelve months Quick Ratio Statistics
High Average Low
0.8 0.39 0.11
(Jun 30 2016)   (Sep 30 2013)




Companies with similar Quick Ratio in the quarter ending Jun 30 2017, within Biotechnology & Pharmaceuticals Industry Quick RatioJun 30 2017 MRQ Cash & cash equivalentJun 30 2017 MRQ Current Liabilities
Windtree Therapeutics Inc  0.12 $ 2.528  Millions$ 21.454  Millions
Xtant Medical Holdings Inc   0.08 $ 1.665  Millions$ 20.845  Millions
Creative Medical Technology Holdings Inc   0.08 $ 0.104  Millions$ 1.314  Millions
Champions Oncology Inc   0.07 $ 0.430  Millions$ 6.020  Millions
Moderna Inc   0.06 $ 0.264  Millions$ 4.159  Millions
Cannabis Global Inc.  0.05 $ 0.005  Millions$ 0.092  Millions
Ds Healthcare Group, Inc.  0.05 $ 0.273  Millions$ 5.823  Millions
Glucose Health, Inc.  0.04 $ 0.018  Millions$ 0.477  Millions
Spotlight Innovation Inc.  0.04 $ 0.128  Millions$ 3.522  Millions
Mymetics Corporation  0.03 $ 1.623  Millions$ 56.053  Millions
Premier Biomedical Inc  0.02 $ 0.125  Millions$ 6.505  Millions
Zeo Scientifix Inc   0.02 $ 0.046  Millions$ 3.004  Millions

Date modified: 2026-09-08T15:08:55+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.